Dazopride
Overview of the drug Dazopride
| Dazopride | |
|---|---|
|
|
Dazopride is a pharmaceutical drug that acts as a gastroprokinetic agent and antiemetic. It is primarily used in the treatment of gastrointestinal disorders and to prevent nausea and vomiting.
Pharmacology[edit]
Dazopride functions by enhancing the motility of the gastrointestinal tract. It achieves this by acting as a serotonin receptor agonist, specifically targeting the 5-HT4 subtype. This action facilitates the release of acetylcholine in the enteric nervous system, which in turn stimulates peristalsis.

In addition to its prokinetic effects, Dazopride also exhibits antiemetic properties. It is believed to exert these effects through antagonism of the 5-HT3 receptors, which are involved in the emetic response.
Clinical Uses[edit]
Dazopride is used in the management of conditions such as gastroparesis, where delayed gastric emptying causes symptoms like bloating, nausea, and vomiting. It is also employed in the prevention of postoperative nausea and vomiting (PONV) and chemotherapy-induced nausea and vomiting (CINV).
Side Effects[edit]
Common side effects of Dazopride include headache, dizziness, and diarrhea. In some cases, patients may experience abdominal pain or cramping. As with any medication, there is a risk of allergic reactions, which can manifest as rash, itching, or swelling.
Mechanism of Action[edit]
Dazopride's dual mechanism of action involves both agonistic and antagonistic effects on serotonin receptors. By stimulating the 5-HT4 receptors, it enhances gastrointestinal motility, while its antagonistic action on 5-HT3 receptors helps to mitigate nausea and vomiting.
Related pages[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian